Skip to main content
Clinical Trials/NCT06002854
NCT06002854
Completed
Phase 2

Comparison Of The Outcome Of Treatment of Microneedling With Autologous Platelet- Rich -Plasma Versus Microneedling With Topical Insulin In The Treatment Of Post Acne Atrophic Scars.

Jinnah Postgraduate Medical Centre1 site in 1 country50 target enrollmentStarted: August 1, 2022Last updated:

Overview

Phase
Phase 2
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
Efficacy of Topical Insulin R with microneedling versus Platelets rich plasma in atrophic acne scars

Overview

Brief Summary

Microneedling with topical INSULIN is a simple, effective tool for building body's new collagen layers and thus an alternative to all erosive techniques such as lasers, peels. The skin responds to fine punctures with the release of growth factors. 8 It is a safe procedure that can be performed in the office without complications, with a good cost-benefit because it is economically viable without any effect on patient's daily activities. 9

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • postacne atrophic scars ≥ 2 on Goodman and Baron's acne scar-grading system
  • Either gender.
  • Age 20-50 years.

Exclusion Criteria

  • lactation and pregnancy
  • skin cancers and infection
  • photosensitivity like SLE ,XP
  • use of RETINOIDS in last 6 months.

Arms & Interventions

GROUP A Microneedling with PRP(platelete rich plasma)

Experimental

Intervention: PRP( platelet rich plasma) and Insulin human (Drug)

GROUP B Microneedling with topical INSULIN

Experimental

Intervention: PRP( platelet rich plasma) and Insulin human (Drug)

Outcomes

Primary Outcomes

Efficacy of Topical Insulin R with microneedling versus Platelets rich plasma in atrophic acne scars

Time Frame: Efficacy will be assesed upto 4 months.

Efficacy will be assessed by using Goodman and Baron Qualitative Scar Grading System

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Nazia Jabeen

Principal Investigator

Jinnah Postgraduate Medical Centre

Study Sites (1)

Loading locations...

Similar Trials